Ali Amirkhosravi
Institute of Translational Research
Florida Hospital
Orlando
Florida 32804
USA
Name/email consistency: high
- The role of tissue factor pathway inhibitor in tumor growth and metastasis. Amirkhosravi, A., Meyer, T., Amaya, M., Davila, M., Mousa, S.A., Robson, T., Francis, J.L. Semin. Thromb. Hemost. (2007)
- Antimetastatic effect of tinzaparin, a low-molecular-weight heparin. Amirkhosravi, A., Mousa, S.A., Amaya, M., Francis, J.L. J. Thromb. Haemost. (2003)
- Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454. Amirkhosravi, A., Mousa, S.A., Amaya, M., Blaydes, S., Desai, H., Meyer, T., Francis, J.L. Thromb. Haemost. (2003)
- Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma. Amirkhosravi, A., Meyer, T., Chang, J.Y., Amaya, M., Siddiqui, F., Desai, H., Francis, J.L. Thromb. Haemost. (2002)
- Platelet-CD40 ligand interaction with melanoma cell and monocyte CD40 enhances cellular procoagulant activity. Amirkhosravi, A., Amaya, M., Desai, H., Francis, J.L. Blood Coagul. Fibrinolysis (2002)









